The expression levels of IL12A [10] and KIR3DL2 [45] in lung adenocarcinoma, and KIR3DL2 in lung squamous cell carcinoma were significantly lower than in adjacent normal tissues and decreased as the clinical stage increased. This evidence concerns the gene KIR3DL2 and squamous cell lung carcinoma.